On September 2, 2020 XOMA Corporation (NASDAQ: XOMA) reported its Chief Executive Officer, Jim Neal, will present at two upcoming investor conferences (Press release, Xoma, SEP 2, 2020, View Source [SID1234564320]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 22nd Annual Global Investment Conference. The presentation will take place on Monday, September 14, 2020, at 2:00 PM ET.
Cantor Fitzgerald Virtual Global Healthcare Conference. The presentation will take place on Tuesday, September 15, 2020, at 4:00 PM ET.
Live webcasts of each presentation can be accessed by visiting the investor relations section of the Company’s website at www.xoma.com. Replays of both presentations will be available and archived on the site for 90 days after the event.

On September 2, 2020 Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, reported that Michael Kauffman, MD, PhD, Chief Executive Officer of Karyopharm, will participate in a fireside chat at Baird’s 2020 Global Healthcare Conference and at the Morgan Stanley 18th Annual Global Healthcare Conference (Press release, Karyopharm, SEP 2, 2020, View Source [SID1234564318]). Details regarding these September conferences are below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird’s 2020 Global Healthcare Conference
Date: Wednesday, September 9
Time: 10:15 AM ET

Morgan Stanley’s 18th Annual Global Healthcare Conference
Date: Tuesday, September 15
Time: 5:00 PM ET

A live webcast of the fireside chats can be accessed under "Events & Presentations" in the Investor section of the Company’s website, View Source A replay of the webcast will be archived on the Company’s website for 90 days following each fireside chat.

On September 2, 2020 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that the company’s management will participate in the following investor conferences during the month of September 2020 (Press release, Affimed, SEP 2, 2020, View Source [SID1234564315]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Wells Fargo Virtual Healthcare Conference (September 9-10, 2020)
Date: Wednesday, September 9, 2020
Presentation Time: Fireside chat with Dr. Jim Birchenough at 8:00 a.m. Eastern Time

Citi’s 15th Annual BioPharma Virtual Conference (September 8-11, 2020)
Date: Wednesday, September 10, 2020
Affimed will host meetings with investors at the conference

Cantor Fitzgerald Virtual Global Healthcare Conference 2020 (September 15-17, 2020)
Date: Thursday, September 17, 2020
Presentation Time: 12:40 p.m. Eastern Time

Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit (September 21-23, 2020)
Date: Monday, September 21, 2020
Presentation Time: 3:20 p.m. Eastern Time
Location: Virtual

Webcasts of each presentation may be accessed on Affimed’s website at View Source For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at [email protected] or phone at (917) 436-8102.

On September 2, 2020 argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, reported that members of management will participate in several upcoming conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird Global Healthcare Conference. Fireside chat on Wednesday, September 9, 2020 at 12:15 p.m. ET.
Morgan Stanley Global Healthcare Conference. Fireside chat on Monday, September 14, 2020 at 1:30 p.m. ET.
BofA Global Healthcare Conference. Fireside chat on Thursday, September 17, 2020 at 10:50 a.m. BST.
Stifel Immunology & Inflammation Summit. Panel on Thursday, October 1, 2020 at 11:00 a.m. ET.
Additional information regarding these events will be available on the Company’s website at www.argenx.com.

On September 2, 2020 Decibel Therapeutics, a clinical-stage biotechnology company developing novel gene therapeutics for restoration of hearing loss and balance disorders, reported that Laurence Reid Ph.D., Chief Executive Officer of Decibel, will present at Citi’s 15th Annual BioPharma Virtual Conference on Tuesday, September 8, 2020 at 1:10pm ET (Press release, Decibel Therapeutics, SEP 2, 2020, View Source [SID1234564312]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!